PAR 0.00% 20.0¢ paradigm biopharmaceuticals limited..

Current SP appreciation, page-21

  1. 3,156 Posts.
    lightbulb Created with Sketch. 331
    Very interesting indeed@Philley as we had another vet on the forum recently who seemed to suggest Pentasan was very hit and miss. I was personally a little suspect about their appraisal, but this was just my take on it based on language and presentation of posts. Nice to read the analysis from your partner from her 40 years of veterinary experience. Thanks for posting.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.